Publication date: Available online 19 November 2026 Source: The Lancet Obstetrics, Gynaecology, & Women's Health Author(s): Andreas Obermair, Andrew Martin, Monika M Janda
Applying the IDEAL framework to the ANVU trial in rare vulvar cancer. // The Lancet Obstetrics, Gynaecology, & Women’s Health. – URL: https://www.sciencedirect.com/science/article/pii/S3050503826003353?dgcid=rss_sd_all
Applying the IDEAL framework to the ANVU trial in rare vulvar cancer. The Lancet Obstetrics, Gynaecology, & Women’s Health. https://www.sciencedirect.com/science/article/pii/S3050503826003353?dgcid=rss_sd_all
“Applying the IDEAL framework to the ANVU trial in rare vulvar cancer.” The Lancet Obstetrics, Gynaecology, & Women’s Health.
@article{article119673,
title = {Applying the IDEAL framework to the ANVU trial in rare vulvar cancer},
journal = {The Lancet Obstetrics, Gynaecology, \& Women’s Health},
url = {https://www.sciencedirect.com/science/article/pii/S3050503826003353?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez